Technical Analysis for CMPS - COMPASS Pathways Plc
| ADX | Long Term | Intermediate Term | Short Term |
|---|---|---|---|
| Weak or Absent | N/A | N/A | Down |
| Historical CMPS trend table... | |||
| Date | Alert Name | Type | % Chg |
|---|---|---|---|
| Hot IPO Pullback | Bullish Swing Setup | 0.00% | |
| Outside Day | Range Expansion | 0.00% | |
| Oversold Stochastic | Weakness | 0.00% | |
| Hot IPO Pullback | Bullish Swing Setup | 7.46% | |
| Narrow Range Bar | Range Contraction | 7.46% | |
| Stochastic Reached Oversold | Weakness | 7.46% | |
| Oversold Stochastic | Weakness | 7.46% | |
| Fell Below 20 DMA | Bearish | 4.49% | |
| Hot IPO Pullback | Bullish Swing Setup | 4.49% | |
| Crossed Above 20 DMA | Bullish | -3.11% |
Recent Intraday Alerts -- Get these alerts pushed to you via our Mobile App
| Alert | Time | |
|---|---|---|
| Trending on StockTwits | 1 day ago | |
| Trending on StockTwits | 2 days ago | |
| 2x Volume Pace | 2 days ago | |
| Possible Pocket Pivot | 2 days ago | |
| Up 1 ATR | 2 days ago |
Get a Trading Sidekick!
Let us help you stay on top of your investments. We will alert you to important technical developments on your
portfolio & watchlist.
Configure default chart indicators
Basic chart:
COMPASS Pathways plc is a mental health care company dedicated to accelerating patient access to evidence-based innovation in mental health. Our focus is on improving the lives of those who are suffering with mental health challenges and who are not helped by current treatments. We are pioneering the development of a new model of psilocybin therapy, in which our proprietary formulation of synthetic psilocybin, COMP360, is administered in conjunction with psychological support. COMP360 has been designated a Breakthrough Therapy by the US Food and Drug Administration (FDA), for treatment-resistant depression (TRD), and we are currently conducting a phase IIb clinical trial of psilocybin therapy for TRD, in 20 sites across Europe and North America. We are headquartered in London, UK, with offices in New York, USA. Our vision is a world of mental wellbeing.
| Indicator | Bull Case | Neutral / Hold | Bear Case |
|---|---|---|---|
| 50 DMA | |||
| 200 DMA | |||
| ADX Trend | |||
| Oversold / Overbought | |||
| Relative Strength |
| Indicator | Value |
|---|---|
| 52 Week High | 47.29 |
| 52 Week Low | 22.53 |
| Average Volume | 851,617 |
| 200-Day Moving Average | 0.00 |
| 50-Day Moving Average | 0.00 |
| 20-Day Moving Average | 37.12 |
| 10-Day Moving Average | 37.03 |
| Average True Range | 4.76 |
| ADX | 0.0 |
| +DI | 26.58 |
| -DI | 14.83 |
| Chandelier Exit (Long, 3 ATRs ) | 33.00 |
| Chandelier Exit (Short, 3 ATRs ) | 47.04 |
| Upper Bollinger Band | 41.40 |
| Lower Bollinger Band | 32.85 |
| Percent B (%b) | 0.46 |
| BandWidth | 23.04 |
| MACD Line | -0.36 |
| MACD Signal Line | -0.01 |
| MACD Histogram | -0.3505 |
| Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
|---|---|---|---|---|---|
| Resistance 4 (R4) | 41.85 | ||||
| Resistance 3 (R3) | 41.28 | 39.02 | 41.00 | ||
| Resistance 2 (R2) | 39.02 | 37.72 | 39.30 | 40.72 | |
| Resistance 1 (R1) | 37.88 | 36.92 | 38.45 | 38.45 | 40.43 |
| Pivot Point | 35.62 | 35.62 | 35.90 | 35.90 | 35.62 |
| Support 1 (S1) | 34.48 | 34.32 | 35.05 | 35.05 | 33.07 |
| Support 2 (S2) | 32.22 | 33.52 | 32.50 | 32.78 | |
| Support 3 (S3) | 31.08 | 32.22 | 32.50 | ||
| Support 4 (S4) | 31.65 |
